HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Kawano Selected Research

Non-Infective Endocarditis

1/2022Heparin treatment ameliorates aortic regurgitation due to malignancy-associated non-bacterial thrombotic endocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Kawano Research Topics

Disease

14Heart Failure
01/2022 - 06/2002
9Cardiomyopathies (Cardiomyopathy)
01/2022 - 11/2003
9Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 09/2003
8Neoplasms (Cancer)
01/2022 - 02/2012
7Infections
12/2021 - 06/2010
7Hypertension (High Blood Pressure)
10/2020 - 02/2003
7Myocardial Infarction
01/2019 - 07/2002
7Cardiovascular Diseases (Cardiovascular Disease)
08/2013 - 07/2002
6Atherosclerosis
09/2022 - 01/2003
6Chest Pain (Chest Pains)
07/2022 - 09/2003
6Hemorrhage
12/2020 - 03/2013
6Spasm (Spasms)
02/2005 - 01/2002
5Atherosclerotic Plaque (Atheroma)
09/2021 - 01/2005
5Thrombosis (Thrombus)
01/2021 - 01/2015
5Atrial Fibrillation
10/2020 - 01/2015
5Tachycardia (Tachyarrhythmias)
01/2020 - 12/2007
4Pulmonary Hypertension
01/2022 - 11/2014
4Cardiac Arrhythmias (Arrythmia)
09/2021 - 07/2006
4Ventricular Tachycardia
02/2021 - 01/2008
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2020 - 04/2008
4Venous Thromboembolism
02/2020 - 01/2016
4Myocardial Ischemia (Ischemic Heart Diseases)
03/2019 - 02/2003
4Angina Pectoris
01/2019 - 05/2004
4Hypotension (Low Blood Pressure)
01/2019 - 04/2012
4Takotsubo Cardiomyopathy
01/2018 - 01/2011
4Glucose Intolerance
11/2009 - 01/2005
4Fibrosis (Cirrhosis)
01/2007 - 04/2004
3Autonomic Nervous System Diseases (Dysautonomia)
01/2022 - 04/2020
3Rupture
11/2020 - 01/2014
3Pathologic Constriction (Stenosis)
10/2020 - 02/2004
3Pulmonary Embolism
02/2020 - 05/2005
3Diabetes Mellitus
09/2019 - 05/2004
3Vomiting
01/2016 - 08/2011
3Nausea
01/2016 - 08/2011
3Postoperative Nausea and Vomiting (PONV)
01/2016 - 08/2011
3Heart Arrest (Cardiac Arrest)
09/2011 - 12/2006
3Ventricular Fibrillation
02/2010 - 09/2006
3Hypercholesterolemia
09/2006 - 04/2002
3Muscle Spasticity (Spastic)
02/2004 - 09/2003
2Hyperemia
09/2022 - 01/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2022 - 06/2010
2Myocarditis (Carditis)
08/2022 - 12/2006
2Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2022 - 10/2020
2Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 12/2012
2Aortic Valve Insufficiency (Aortic Regurgitation)
01/2022 - 01/2021
2Septic Shock (Toxic Shock Syndrome)
11/2021 - 04/2012
2Hypoxia (Hypoxemia)
11/2020 - 05/2005
2Diabetic Nephropathies (Diabetic Nephropathy)
10/2020 - 11/2017
2Hyperplasia
01/2020 - 12/2007
2Obesity
01/2020 - 01/2013
2Body Weight (Weight, Body)
04/2019 - 01/2011

Drug/Important Bio-Agent (IBA)

6Brain Natriuretic Peptide (Natrecor)FDA Link
12/2021 - 06/2002
5IronIBA
12/2021 - 12/2013
5Factor Xa InhibitorsIBA
02/2020 - 01/2015
5Anesthetics (Anesthetic Agents)IBA
12/2012 - 04/2009
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 11/2020
4Prealbumin (Transthyretin)IBA
01/2022 - 11/2020
4CreatinineIBA
04/2019 - 07/2002
4ThioredoxinsIBA
11/2005 - 01/2004
4Acetylcholine (Acetylcholine Chloride)FDA Link
02/2005 - 07/2002
3C-Reactive ProteinIBA
04/2022 - 04/2004
3Pharmaceutical PreparationsIBA
12/2021 - 01/2019
3CholesterolIBA
09/2021 - 05/2004
3Antihypertensive Agents (Antihypertensives)IBA
10/2020 - 09/2006
3RivaroxabanIBA
02/2020 - 01/2015
3AnticoagulantsIBA
02/2020 - 01/2018
3Nicorandil (SG 75)IBA
03/2019 - 08/2010
3AntiemeticsIBA
01/2016 - 08/2011
3HDL CholesterolIBA
01/2011 - 05/2004
3Glucose (Dextrose)FDA LinkGeneric
06/2009 - 11/2005
3Plasminogen InactivatorsIBA
05/2004 - 01/2003
2Proteins (Proteins, Gene)FDA Link
08/2022 - 09/2021
2LDL CholesterolIBA
04/2022 - 01/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2013
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 09/2020
2Troponin T (Troponin T1)IBA
12/2021 - 11/2020
2Indicators and Reagents (Reagents)IBA
12/2021 - 01/2007
2Fluspirilene (Imap)IBA
12/2021 - 01/2015
2PotassiumIBA
12/2020 - 08/2010
2FebuxostatFDA Link
11/2020 - 09/2020
2Xanthine OxidaseIBA
11/2020 - 09/2020
2Uric Acid (Urate)IBA
09/2020 - 09/2019
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2020 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2020 - 07/2002
2Amiodarone (Amiodarona)FDA LinkGeneric
08/2020 - 09/2006
2Nitroglycerin (Dynamite)FDA LinkGeneric
03/2019 - 07/2002
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2019 - 11/2018
2Angiotensin Receptor AntagonistsIBA
01/2019 - 09/2003
2Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2006
2edoxabanIBA
01/2018 - 01/2016

Therapy/Procedure

31Therapeutics
08/2022 - 07/2002
9Anesthesia
01/2016 - 04/2009
8General Anesthesia
06/2016 - 04/2010
6Stents
07/2020 - 07/2004
3Catheter Ablation
02/2021 - 01/2008
3Renal Dialysis (Hemodialysis)
10/2020 - 01/2015
3Aftercare (After-Treatment)
01/2017 - 03/2005
3Gynecologic Surgical Procedures (Gynecologic Surgery)
01/2016 - 08/2011
3Drug Therapy (Chemotherapy)
01/2016 - 01/2013
3Cardiac Resynchronization Therapy
01/2014 - 11/2003